Cargando…

HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing

BACKGROUND: The Department of Health and Human Services HIV-1 Treatment Guidelines recommend drug resistance testing in HIV-1 RNA to guide the selection of antiretroviral therapy in patients with viremia. However, resistance-associated mutations (RAMs) in HIV-1 RNA may reflect only the patient’s cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curanovic, Dusica, Martens, Sharon K, Rodriguez, Milka A, Hammill, Hunter A, Petropoulos, Christos J, Walworth, Charles M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096913/ https://www.ncbi.nlm.nih.gov/pubmed/37065991 http://dx.doi.org/10.1093/ofid/ofad146

Ejemplares similares

959. HIV-1 DNA Testing Identifies Drug Resistance in Viremic Patients with Pan-Sensitive Plasma Virus
por: Curanovic, Dusica, et al.
Publicado: (2020)

691. Results of Repeat HIV-1 DNA Resistance Tests Are Highly Concordant
por: Curanovic, Dusica, et al.
Publicado: (2020)

117. Trends in Four-class HIV Drug Resistance in Treatment-experienced Patients in the United States
por: Curanovic, Dusica, et al.
Publicado: (2021)

2686. High HIV and STI Rates in Patients with MPOX Identified in a Large National Database
por: Alfego, David, et al.
Publicado: (2023)

Elite and viremic HIV-1 controllers in West Africa
por: N’takpé, Jean Baptiste, et al.
Publicado: (2022)

Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4(+) T-Cell Counts in People With HIV
por: Rocco, Joseph M, et al.
Publicado: (2020)

HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?
por: Neilan, Anne M, et al.
Publicado: (2018)

Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment
por: Ellis, Ronald J., et al.
Publicado: (2022)

Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Patients With HIV Infection
por: Sobczyk, Juliana, et al.
Publicado: (2020)

HIV Testing in Adults Presenting With Central Nervous System Infections
por: Ma, Bert, et al.
Publicado: (2020)

Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection
por: Singh, Amit Kumar, et al.
Publicado: (2020)

Receipt of Baseline Laboratory Testing Recommended by the HIV Medicine Association for People Initiating HIV Care, United States, 2015–2019
por: Weiser, John, et al.
Publicado: (2022)

A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects
por: Brown, Jennifer, et al.
Publicado: (2014)

Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
por: Bar-On, Yotam, et al.
Publicado: (2018)

HIV Testing Approaches to Optimize Prevention and Treatment for Key and Priority Populations in Malawi
por: Rucinski, Katherine, et al.
Publicado: (2022)

Viremic long-term nonprogressive HIV-1 infection is not associated with abnormalities in known Nef functions
por: Heigele, Anke, et al.
Publicado: (2014)

Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses
por: Salgado, Maria, et al.
Publicado: (2018)

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors
por: Colomer-Lluch, Marta, et al.
Publicado: (2022)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers
por: Gonzalo-Gil, Elena, et al.
Publicado: (2017)

Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART
por: Riddler, Sharon A, et al.
Publicado: (2018)

Geospatial Analysis of Time to Human Immunodeficiency Virus (HIV) Diagnosis and Adult HIV Testing Coverage Highlights Areas for Intervention in the US Southeast
por: Matthews, Lynn T, et al.
Publicado: (2023)

Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection
por: Hermans, Lucas E, et al.
Publicado: (2022)

Finger-Stick Whole Blood HIV-1/-2 Home-Use Tests Are More Sensitive than Oral Fluid-Based In-Home HIV Tests
por: Jaspard, Marie, et al.
Publicado: (2014)

Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South Africa
por: Stanic, Tijana, et al.
Publicado: (2021)

Missed Opportunities for HIV Testing of Patients Tested for Sexually Transmitted Infections at a Large Urban Health Care System From 2010 to 2015
por: Kapadia, Shashi N, et al.
Publicado: (2018)

Multisite Laboratory Evaluation of a Dual Human Immunodeficiency Virus (HIV)/Syphilis Point-of-Care Rapid Test for Simultaneous Detection of HIV and Syphilis Infection
por: Bristow, Claire C., et al.
Publicado: (2014)

HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2019)

Urine Lipoarabinomannan Testing for All HIV Patients Hospitalized in Medical Wards Identifies a Large Proportion of Patients With Tuberculosis at Risk of Death
por: Huerga, Helena, et al.
Publicado: (2020)

Sustained Viremic Control in HIV-Infected Patient: Case Report from Nepal
por: Khadka, Sundar, et al.
Publicado: (2018)

Lack of Detectable HIV-1–Specific CD8(+) T Cell Responses in Zambian HIV-1–Exposed Seronegative Partners of HIV-1–Positive Individuals
por: Addo, Marylyn M., et al.
Publicado: (2011)

I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV
por: Cheru, Lediya T, et al.
Publicado: (2018)

Comparison of functioning and health-related quality of life among patients with HTLV-1, HIV, and HIV-HTLV-1-coinfection
por: Marconi, Cleyde Sheyla Chachaqui, et al.
Publicado: (2021)

Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load
por: Grant-McAuley, Wendy, et al.
Publicado: (2023)

Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART)
por: Fogel, Jessica M, et al.
Publicado: (2022)

Decreased Mutation Frequencies among Immunoglobulin G Variable Region Genes during Viremic HIV-1 Infection
por: Bowers, Elisabeth, et al.
Publicado: (2014)

Impact of HIV-1 Resistance-Associated Mutations on Susceptibility to Doravirine: Analysis of Real-World Clinical Isolates
por: Asante-Appiah, Ernest, et al.
Publicado: (2021)

Sensitivity and Specificity of Rapid Diagnostic Tests for Hepatitis C Virus With or Without HIV Coinfection: A Multicentre Laboratory Evaluation Study
por: Vetter, Beatrice N, et al.
Publicado: (2020)

Effect of Social Determinants of Health on Uncontrolled Human Immunodeficiency Virus (HIV) Infection Among Persons With HIV in San Francisco, California
por: Melo, Jason S, et al.
Publicado: (2022)

Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco
por: Hughes, Alison J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hp2dm6t5ciepg3c8lie6mru1aq